Division of HIV, Infectious Diseases & Global Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco.
Department of Medicine, University of California San Francisco, San Francisco.
Am J Med. 2022 Jan;135(1):91-96. doi: 10.1016/j.amjmed.2021.08.007. Epub 2021 Sep 9.
Despite the high burden of Staphylococcus aureus infections among persons who use drugs, limited data exist comparing outcomes of patient-directed discharge (known as discharge against medical advice) compared with standard discharge among persons who use drugs hospitalized with S. aureus infection.
We conducted a retrospective study of hospitalizations among adults with S. aureus bacteremia, endocarditis, epidural abscess, or vertebral osteomyelitis at 2 San Francisco hospitals between 2013 and 2018. We compared odds of 1-year readmission for infection persistence or recurrence and 1-year mortality via multivariable logistic regression models adjusting for age, sex, Charlson comorbidity index, and homelessness.
Overall, 80 of 340 (24%) of hospitalizations for invasive S. aureus infections among persons who use drugs involved patient-directed discharge. More than half of patient-directed discharges 41 of 80 (51%) required readmission for persistent or recurrent S. aureus infection compared with 54 of 260 (21%) patients without patient-directed discharge (adjusted odds ratio 3.8, 95% confidence interval [CI] 2.2-6.7). One-year cumulative mortality was 15% after patient-directed discharge compared with 11% after standard discharge (P = .02); however, this difference was not significant after adjustment for mortality risk factors. More than half of deaths in the patient-directed discharge group (7 of 12, 58%) were due to drug overdose; none was due to S. aureus infection.
Among persons who use drugs hospitalized with invasive S. aureus infection, odds of hospital readmission for infection were almost 4-fold higher following patient-directed discharge compared with standard discharge. All-cause 1-year mortality was similarly high in both groups, and drug overdose was a common cause of death in patient-directed discharge group.
尽管在使用毒品的人群中,金黄色葡萄球菌感染的负担很高,但在因金黄色葡萄球菌感染住院的使用毒品者中,与标准出院相比,患者自行出院(称为医嘱出院)的结果比较数据有限。
我们对 2013 年至 2018 年期间在旧金山的 2 家医院住院的金黄色葡萄球菌菌血症、心内膜炎、硬膜外脓肿或脊椎骨髓炎的成年人进行了回顾性研究。我们通过多变量逻辑回归模型比较了 1 年内因感染持续或复发和 1 年内死亡率的可能性,调整了年龄、性别、Charlson 合并症指数和无家可归情况。
总体而言,在 340 例因侵袭性金黄色葡萄球菌感染住院的使用毒品者中,有 80 例(24%)涉及医嘱出院。与没有医嘱出院的 260 例患者相比,医嘱出院的 80 例中有 41 例(51%)需要因持续或复发的金黄色葡萄球菌感染而再次入院,而 41 例(51%)需要因持续或复发的金黄色葡萄球菌感染而再次入院(调整后的比值比为 3.8,95%置信区间为 2.2-6.7)。医嘱出院后 1 年累积死亡率为 15%,而标准出院后为 11%(P=0.02);然而,在调整了死亡率危险因素后,这一差异并不显著。在医嘱出院组中,超过一半的死亡(7 例中的 12 例,58%)是由于药物过量;没有因金黄色葡萄球菌感染而死亡。
在因侵袭性金黄色葡萄球菌感染住院的使用毒品者中,与标准出院相比,医嘱出院后因感染再次住院的可能性几乎高出 4 倍。两组的全因 1 年死亡率均较高,且医嘱出院组中药物过量是常见的死亡原因。